15353-j-veluchamy

5 Towards UCB-NK cells treatment in colorectal cancer | 137 27. Tannous BA. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nature protocols (2009) 4 (4):582-91. Epub 2009/04/18. doi: 10.1038/nprot.2009.28. PubMed PMID: 19373229; PubMed Central PMCID: PMCPmc2692611. 28. Rafique M, Adachi W, Koike S, Kajikawa S, Yazawa K, Sugenoya A, et al. Adverse effects of intraportal chemotherapy on natural killer cell activity in colorectal cancer patients. Journal of surgical oncology (1997) 64 (4):324-30. Epub 1997/04/01. PubMed PMID: 9142191. 29. Lehmann D, Spanholtz J, Osl M, Tordoir M, Lipnik K, Bilban M, et al. Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells. Stem cells and development (2012) 21 (16):2926- 38. Epub 2012/05/11. doi: 10.1089/scd.2011.0659. PubMed PMID: 22571679; PubMed Central PMCID: PMCPmc3475144. 30. Gill S, Vasey AE, De Souza A, Baker J, Smith AT, Kohrt HE, et al. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood (2012) 119 (24):5758-68. Epub 2012/05/01. doi: 10.1182/ blood-2012-03-415364. PubMed PMID: 22544698; PubMed Central PMCID: PMCPMC3382935. 31. Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunology today (1990) 11 (7):237-44. Epub 1990/07/01. PubMed PMID: 2201309. 32. Sandel MH, Speetjens FM, Menon AG, Albertsson PA, Basse PH, Hokland M, et al. Natural killer cells infiltrating colorectal cancer and MHC class I expression. Molecular immunology (2005) 42 (4):541-6. Epub 2004/12/21. doi: 10.1016/j.molimm.2004.07.039. PubMed PMID: 15607811. 33. Maleno I, Aptsiauri N, Cabrera T, Gallego A, Paschen A, Lopez-Nevot MA, et al. Frequent loss of heterozygosity in the beta2-microglobulin region of chromosome 15 in primary human tumors. Immunogenetics (2011) 63 (2):65-71. Epub 2010/11/19. doi: 10.1007/s00251-010-0494-4. PubMed PMID: 21086121. 34. Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer (1997) 79 (12):2320-8. Epub 1997/06/15. PubMed PMID: 9191519. 35. Peng Y-P, Zhu Y, Zhang J-J, Xu Z-K, Qian Z-Y, Dai C-C, et al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. Journal of Translational Medicine (2013) 11 (1):1-10. doi: 10.1186/1479-5876-11-262. 36. Villegas FR, Coca S, Villarrubia VG, Jimenez R, Chillon MJ, Jareno J, et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung cancer (Amsterdam, Netherlands) (2002) 35 (1):23-8. Epub 2001/12/26. PubMed PMID: 11750709. 37. Ishigami S, Natsugoe S, Tokuda K, NakajoA, Che X, IwashigeH, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer (2000) 88 (3):577-83. Epub 2000/01/29. PubMed PMID: 10649250.